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C-H Activation / metalation approaches for the synthesis of 
indolizine derivatives 
Camila R. de S. Bertallo, [a] Thais R. Arroio,[a] Mônica F. Z. J. Toledo,[a] Scott D. Saddler,[b] Ricardo 
Vessecchi,[c] Patrick G. Steel,*[b] Giuliano C. Clososki*[a,c] 
 
Abstract: The C-H borylation of indolizines has not previously been 
reported and in this communication, we describe our preliminary 
efforts to apply this chemistry to this scaffold and contrast this 
approach to directed metalation. Through these methodologies were 
possible obtain a library of substituted indolizines functionalized in 
both pyridinic and pyrrole ring. 
Introduction 
Indolizines represent a privileged class of heterocycles that have 
received considerable attention recently due to their significant 
and broad range of activities (Figure 1). This include roles in many 
biological active compounds such as anti-inflammatory,1 
anticancer,2 antimicrobial,3 and antitubercular agents, among 
others.4–12 In addition, owing to the luminescent properties of this 
ring system, indolizine derivatives have found applications as 
bioprobes in pH and turn-on/off fluorescent sensors,13–15 in the 
detection of volatile organic compounds,16 lipid droplet 
accumulation,17 and in cell labeling.18 Moreover, substituted 
indolizines have found roles in organic sensitizer components for 
photoresponsive materials19 and dye-sensitized solar cells.20 
 
 
Figure 1. Some indolizines that present biological activity. 
 
This diversity of function has encouraged the search for new and 
efficient methods to generate novel analogues. Aromatic 
indolizines are commonly prepared from pyridines and pyrroles 
by several synthetic strategies including the classic 
Tschitschibabin reaction, cycloaddition reactions, intramolecular 
cyclizations, and cycloisomerisations.21-24 However, late stage 
modification of a preformed indolizine ring can be desirable and 
several strategies have been described. Given the electron rich 
nature of the heterocyclic ring electrophilic substitution is 
relatively facile leading to preferential substitution at C-1 and C-
3.25 Selective C-3 substitution can be achieved through palladium 
catalyzed C-H activation, although this probably also proceeds via 
a SEAr mechanism. Direct lithiation of the ring is also possible. 
First reported by Renald and Gubin using 2-phenylindolizine as 
substrate,26 this approach can be used to access a range of C-5 
functionalized derivatives.27 One limitation of this approach is 
functional group tolerance to the bases employed. In this regard 
we have been exploring the direct metalation of indolizines as well 
as other N-heterocycles28 using lithium and the mixed lithium-
magnesium bases TMPMgClLiCl and TMP2Mg2LiCl (TMP= 
2,2,6,6-tetramethylpiperidinyl).29 Using indolizine-1-carboxylates 
as a model substrates the selective synthesis of a variety of C-2 
and C-5 difunctionalized indolizines could be achieved.28e An 
alternative functional group tolerant approach to C-H activation 
that is gaining significant popularity is C-H borylation mediated by 
Iridium tris-boryl complexes.30  The C-H borylation of indolizines 
has not previously been reported and in this communication, we 
describe our preliminary efforts to apply this chemistry to this 
scaffold and contrast this approach to directed metalation. 
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Results and Discussion 
With the aim of comparing the two C-H activation procedures we 
selected a small focused set of indolizines containing functional 
groups that have previously been shown to enable directed 
metalation chemistry. The nitriles (5, 6) and diester 9 could easily 
be prepared through cycloaddition of pyridine derived ylid and the 
acrylonitrile and dimethyl fumarate respectively.31 
With substrates in hand we then considered their borylation using 
as a standard reagent, the catalyst derived from [Ir(OMe)cod]2/ 
dtbpy (4,4’-di-t-butylbipyridine) and B2Pin2 as the source of 
boron.32,33 As the Ir catalyzed borylation of the parent indolizine 
has not been previously reported we initially explored this 
substrate to ascertain if there was any intrinisic selectivity within 
this heterocyclic scaffold. Surpringly, given the latent azole within 
the indolizine structure this proved to be a rather reluctant 
substrate requiring elevated temperatures (80˚C) to observe any 
significant reactivity. Moreover, in line with many unsubstitued 
polycyclic arenes, at this temperature, the unhindered nature of 
the substrate led to a complex mixture of both mono- and bis-
borylated products. Introduction of an additional heteratom into 
the five membered ring (compounds 1 and 3) enhanced the 
reactivity with borylation occurring  remote from the azinyl 
nitrogen as would be expected .34 In both cases the initially formed 
boronate ester proved difficult to purify and confirmation of 
regiochemistry was obtained by in situ Suzuki-Miyaura cross 
coupling reactions that afforded products 2 and 4 in 31 and 41% 
yields, respectively  (Scheme 1). 
 
Scheme 1.  C-H borylations of 1 and 3 followed by Suzuki-Miyaura cross 
coupling reactions. 
The addition of an electron withdrawing substituent is also well 
known to be strongly activating towards borylation. In particular, 
benzonitriles are viable substrates in which the substituent has 
only a limited steric influence. In line with this precedent, 2-
cyanoindolizine 5 reacted to afford a complex mixture of mono-
borylated and di-borylated products (Scheme 2, equation a). 
Within this, substitution at C-1 and C-3 in the five membered ring 
was favored consistent both with the known propensity for a 
nitrile to activate ortho C-H bonds to borylation and the high 
reactivity of azole rings.  Whilst at higher temperatures and 
longer reactions time 1-cyanoindolizine 6 gave a similar output, 
lowering both the reaction temperature and time led to the 
formation of only two regioisomers at C-3 (compound 7a) or C-6 
(compound 8a), albeit with only low conversion (45% by GC/MS). 
As isolation of the boronate esters was challenging it proved 
more practical to undertake a one pot conversion to the 
corresponding biaryls (7a, 7b, 8a and 8b) which could be 
achieved in moderate overall yields (Scheme 2, equations b and 
c).  Subsequently, we then turned to explore the diester 9. 
Pleasingly, this combination of greater steric influence coupled 
with a strong electron withdrawing effect proved to be successful. 
After some experimentation, the best combination of selectivity 
and conversion (87% by GC/MS) was achieved using MTBE as 
solvent with 5 mol% of [Ir(OMe)cod]2, 10 mol% dtbpy and 1.0 
equivalent of B2Pin2 at 80°C for 4h. This led to a mixture of 
borylated products that proved difficult to resolve so a one pot 
tandem C–H borylation Suzuki–Miyaura cross coupling process 
was established. In this, following completion of the borylation 
step, the reaction mixture was concentrated in vacuo and 
Pd(dppf)Cl2, K3PO2 and dimethylacetamide (DMAc)/H2O (2:1) 
added.35 As shown in equation d (Scheme 2), this led to the 
formation of two arylated indolizine regioisomers (compounds 10 
and 11) and a di-arylated product 12 with the major product being 
the C-5 arylated product 10 (48% isolated yield). The formation 
of the C-5,6 diarylated derivative 12 was particularly intriguing as 
the possibility of formation of an intermediate with ortho Bpin 
groups is normally sterically inhibited.  
 
Scheme 2. C-H borylation of 5, 6 and 9 followed by Suzuki-Miyaura cross 
coupling reactions. 
Having demonstrated that the borylation of indolizines was 
possible we then turned to examine the substituted indolizines (5, 
6 and 9) in the direct metalation process. In all cases we used the 
trapping reaction with iodine as a standard marker of selectivity. 
We had previously employed the directed regioselective 
metalation of 1-ester-substituted indolizines using LDA and 
TMPMgClLiCl under mild conditions. Application of this strategy 
allowed the synthesis of a variety of C-2 and C-5 difunctionalized 
indolizines after reaction of the corresponding organometallic 
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intermediates with different electrophiles.28e In a similar fashion, 
we evaluated the reactivity of diester 9 using lithium and 
magnesium amides.  Interesting, albeit no reaction was observed 
using LDA or TMPLi, the metalation occurred smoothly at room 
temperature within 5h using 2 equivalents of TMPMgCl∙LiCl, as 
verified by CG-MS analysis of the crude reaction mixtures 
quenched with iodine. On a preparative scale, solvent extraction 
and purification with flash chromatography allowed iodide 13a to 
be isolated in 87% yield (Table 1, entry 1). Moreover, quenching 
intermediate with dimethylformamide gave the trisubstituted 
indolizine bearing an aldehyde group at C-5 position 13b with 
60% yield (Table 1, entry 2). Remarkably, as already observed in 
other indolizine substrates,29 a regioselectivity dependent upon 
the electrophile was observed when the reaction was quenched 
with diphenyldisulfide to give 14a (Table 1, entry 3). The same 
regioselectivity was observed in palladium-catalyzed coupling 
reactions, important tools to functionalize aromatics and 
heterocyclic substrates.36 After, transmetalation of the 
organomagnesium intermediate with ZnCl2, Negishi cross-
coupling reactions with iodobenzene or 1-bromo-4-
(trifluoromethyl)benzene in the presence of [Pd(PPh3)4] (10mol%) 
produced the C-3 arylated derivatives  14b or 14c in 64 and 76% 
yields, respectively (Table 1, entries 4 and 5).   
 
 
 
Table 1. Selective metalation of 5 followed by reaction with electrophiles. 
Entry Electrophile Product    Yield 
(%)[a] 
 
1 I2 
 
87  
2 DMF 
 
60  
3 (C6H5S)2 
 
75  
4 PhI 
 
64[b]  
5 Br(C6H4)CF3 
 
76[b]  
[a]Isolated yields, [b]Obtained via Negishi cross-coupling using 10 mol% 
Pd(PPh3)4 after transmetalation with 2 equiv. of ZnCl2 at rt for 30 min. 
 
This divergence in selectivity potentially arises through a 
dynamic equilibrium between the anionic species since pKa 
calculations (computed at B3LYP/6-31+G(d,p) level in 
Gaussian 03 software)37  indicate similar acidity of the 
hydrogens at C-3 and C-5 positions (Scheme 3).  We speculate 
that the generation of the C-3 anion is favored by chelation of 
the magnesium counter-ion by the proximal ester. Consistent 
with this hypothesis, in situ trapping38 experiments with 
chlorotrimethylsilane afforded the corresponding 3-silylated 
derivative as the major product (see SI). Disruption of the 
chelate by a coordinating electrophile (iodide) allows anion 
equilibration and leads to formation of the sterically less 
hindered anion and formation of the 5-substituted product. In 
contrast reaction with non-coordinating reagents (ZnCl2) traps 
the coordinated anion faster than exchange can occur. Whilst 
a base mediated halogen dance39 provides an alternative 
mechanism that leads to the formation of iodide 13a, that 
cannot be excluded, the order of events with addition of the 
electrophile (I2) only occurring after complete metalation leads 
us to favor the former scenario.   
 
Scheme 3.  Dynamic equilibrium of anionic species derived from the reaction of 
9 with TMPMgClLiCl 
With 1-cyanoindolizine 6, complete metalation was achieved within 
30 min using 1.4 equivalents of LDA at 0°C leading, on reaction 
with iodine, and isobutyraldehyde to the C-5 indolizine derivatives 
15a-b, respectively (Scheme 4, equations a and b).  This result is 
consistent with simple pKa calculations (See SI) which reveal that 
the C-5 hydrogen is the more acidic (pKa 26.0). On switching to 
the magnesium bases, an ortho metalation effect enabled by the 
cyano group was expected leading to the formation of the C-2 
substituted products. However, a dependence on the electrophile 
was again observed with the isobutyraldehyde reacting at C-2 to 
give 16a (Scheme 4, equation c) possibly via a chelate 
mechanism, whilst the iodide, as previously noted, disrupted the 
weak chelation to the nitrile group leading to rapid anion 
isomerization and formation of the C-5 product 15a (Scheme 4, 
equation d). The metalation of 2-cyanoindolizine 5 was best 
achieved using the mixed lithium magnesium bases TMPMgClLiCl 
and TMP2Mg2LiCl. As before, the ultimate product isolated 
depended on the nature of the electrophile. Thus, reaction of 5 with 
3 equivalents of TMPMgClLiCl for 1 hour followed by addition of 
trimethylsilyl chloride gave the C-3 silylated derivative 17b in 67% 
yield (Scheme 4, equation e). Functionalization at C-3 position was 
also observed when the same reaction was quenched with 
hexachloroethane, allowing the isolation of chloride 17b in 62% 
yield (Scheme 4, equation f).  A very similar result was obtained 
when the diamide TMP2Mg2LiCl was used as a base (2 equiv), 
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leading to the same product 17b in 63% yield (Scheme 4, equation 
g). In contrast, quenching the reaction with iodine afforded the C-5 
substituted product 18a in 47% yield (Scheme 4, equation h).  
 
Scheme 4. Selective metalation of cyanoindolizines 5 and 6 
Conclusions 
In this report, we have described for the first time the C-H borylation of 
indolizines, which allowed the synthesis of arylated derivatives after in 
situ Suzuki-Miyaura cross coupling reactions. Directed metalation of the 
same substrates followed by reaction with electrophiles afforded the 
functionalized derivatives in reasonable to good yields, with the 
regioselectivity of the reactions being dependent upon the base and 
electrophile used. DFT calculations illustrated how the substituents 
affect the acidity of the aromatic  hydrogens. In summary, these two 
strategies enable the selective access to a set of substituted indolizines 
functionalized in either pyridinic or pyrrole ring.  The scope of these 
methodologies and their applicability towards the synthesis of 
biologically active molecules are currently being investigated in our 
laboratories. 
Experimental Section 
The solvents were purified according to standard procedures. The 
starting materials were purchased from Sigma-Aldrich Corp. All air-
sensitive and/or water-sensitive reactions were carried out with dry 
solvents under anhydrous conditions and under nitrogen atmosphere. 
Standard syringe techniques were applied for the transfer of dry 
solvents and air-sensitive reagents. The reactions were monitored by 
TLC on Merck silica gel (60 F 254) by using UV light as a visualizing 
agent and 5% vanillin in 10% H2SO4 with heating as a developing agent. 
Sigma– Aldrich silica gel (particle size 0.040–0.063 nm), pre-packed 
silica Redisep® Rf cartridges and pre-packed C18 silica Redisep® Rf 
cartridges (Teledyne Isco CombiFlash Rf machine) were used for flash 
chromatography. NMR spectra were recorded with a Bruker DPX 300, 
400, 500 and 600 (at 300, 400, 500 and 600 MHz for 1H and 75, 100, 
125 and 151 MHz for 13C, respectively.) instrument while using CDCl3 
or DMSO-d6 as solvent. The chemical shifts are reported as δ units in 
parts per million (ppm) relative to the solvent residual peak as the 
internal reference. Infrared (IR) spectra of all synthesized compounds 
were recorded on Perkin-Elmer- mod.1420 in KBr pellets or in a 
Diamond ATR (attenuated total reflection) accessory (Golden Gate). 
Assigned peaks are reported in wavenumbers (cm-1). Mass spectra 
(MS) were measured with Shimadzu GCMS-QP2010 mass 
spectrometer. HRMS spectra were measured with a Bruker Daltonics 
micrOTOF QII/ESI-TOF, LTQFT mass spectrometer or QToF mass 
spectrometer. Dimethyl indolizine-1,2-dicarboxylate, indolizine-1-
carbonitrile, indolizine-2-carbonitrile and [Ir(OMe)cod]2 were prepared 
as previously reported.30  
General Procedure 1A: In a glovebox, a premixed solution of 
[Ir(COD)OMe]2 (1.5 mol%), dtbpy (3 mol%) and B2pin2 (0.5 equiv) (or 
HBpin (1.0 equiv) where stated) in MTBE (2.5 mL) was added to a thick- 
walled microwave synthesis vial containing the stated heterocycle (1.0 
equiv). The mixture was shaken vigorously to ensure complete mixing, 
and then the mixture was stirred at room temperature or heated at 80 ̊C 
for the stated time. In-situ NMR reaction monitoring was carried out. The 
reaction was stirred for 16h at room temperature before being 
concentrated in vacuo. A tandem Suzuki-Miyaura cross-coupling reaction 
was then carried out. To the crude borylation mixture under N2, was 
added Pd(Amphos)Cl2 (40 mg, 0.056 mmol), Na2CO3(aq) (2M, 197 mg, 
1.86 mmol), 3-iodo-fluorobenzene (248 mg, 1.12 mmol) in DME (3 mL) 
at 80°C for 3h.  The reaction mixture was diluted with water and extracted 
into EtOAc. The organic phase was dried over MgSO4, filtered and 
concentrated in vacuo to give the crude product.  
3-(3-fluorophenyl)pyrazolo[1,5-a]pyridine 2: From 3-(3-
fluorophenyl)pyrazolo[1,5-a]pyridine (110 mg, 0,93 mmol) and 3-
iodofluorobenzene (248 mg, 1.12 mmol). Purification by reverse phase 
chromatography using pre-packed C18 silica Redisep® Rf cartridges and 
a 0-100% MeOH in H2O (containing 0.1% HCOOH) gradient elution, 
constant of flow 35 mL/min.  Yield: 61 mg, (31%), pale yellow oil. 1H NMR 
(600 MHz, CDCl3, 25ºC) δ 8.38 (d, J = 7.7, 1H), 8.03 (s, 1H), 7.69 (d, J = 
7.7, 1H), 7.35 (m, 2H), 7.24 (m, 1H), 7.16 (t, J = 7.7, 1H), 6.95 (m, 1 H), 
6.77 (t, J = 7.7, 1H). 13C NMR (151 MHz, CDCl3) δ 163.4 (d, JF,C = 246.0 
Hz), 140.6, 137.1, 135.5, 130.6, 129.3, 124.5, 122.7, 117.4, 113.7 (d, J = 
22.0), 113.0 (d, JF,C = 21.1 Hz), 112.3, 111.9 (d, JF,C = 2.3 Hz). IR νmax 
(ATR) 1634, 1613, 1584, 1546, 1531, 1453, 1366, 1260, 1217, 1178, 
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1017, 904 cm−1. HRMS (ESI) m/z ([M+H]+ calcd for C13H10N2F 213.0828, 
found 213.0814.  
General Procedure 1B : In a glovebox, a premixed solution of 
[Ir(COD)OMe]2 (1.5 mol%), dtbpy (3 mol%) and B2pin2 (1.0 equiv) (or 
HBpin (1.0 equiv) where stated) in MTBE (2.5 mL) was added to a thick- 
walled microwave synthesis vial containing pyrazolo[1,2-a]pyridine 3 
(118 mg, 1 mmol). The mixture was shaken vigorously to ensure 
complete mixing, and then the mixture was stirred at 80 ̊C for 24h. In-
situ NMR reaction monitoring was carried out. The 3-(Bpin) desire 
product was obtained in 85% conversion (1H NMR). The Suzuki-
Miyaura step was carried out for 2h with Pd(Amphos)Cl2 (39 mg, 0.05 
mmol), K3PO4 (425 mg, 2 mmol), 3-iodoanisole (257 mg, 1.1 mmol) in 
DMAc:H2O (10:1) (2.5 mL) at 50°C. The reaction mixture was diluted 
with water and extracted into EtOAc. The organic phase was dried over 
MgSO4, filtered and concentrated in vacuo to give the crude product.  
3-(3-methoxyphenyl)imidazo[1,2-a]pyridine 4: From pyrazolo[1,2-
a]pyridine 3 (118 mg, 1 mmol) and 3-iodoanisole (257 mg, 1.1 mmol).  
Purification was achieved using automated Teledyne Isco CombiFlash 
Rf machine with a pre-packed silica Redisep® Rf cartridges (ethyl 
acetate/hexane 0-50%) at a constant flow rate of 35 mL/min. Yield: 92 
mg (41%), grey amorphous solid. 1H NMR (700 MHz, CDCl3, 25 ºC)  δ  
8.37 (d, J = 7.6, 1H), 7.70 (s, 1H), 7.67 (d, J = 7.6, 1H), 7.43 (t, J = 7.9, 
1H), 7.20 (m, 1H), 7.15 (d, J = 7.9, 1H), 7.09 (m, 1H), 6.96 (dd, J = 7.9, 
1.9, 41H), 6.81 (t, J = 7.6, 1H), 3.87 (s, 3H); 13C NMR (176 MHz, CDCl3) 
δ 160.2, 146.2, 132.6, 130.6, 130.2, 125.6, 124.2, 123.5, 120.2, 118.3, 
113.7, 113.5, 112.5, 55.4. IR νmax (ATR) 1602, 1580, 1501, 1299, 
1283, 1237, 1165, 1047 cm−1; HRMS (ESI) m/z ([M+H]+ calcd for 
C14H13N2O 225.1030, found 225.1019.  
General Procedure 1C: One-pot C-H borylation/Suzuki-Miyaura Cross-
coupling of substituted indolizines 
A thick-walled microwave synthesis vial was charged with the 
corresponding indolizine (0.5 mmol, 1.0 equiv) and degassed MTBE 
(1mL) (vial A). A separate vial was charged with [Ir(COD)OMe]2 (5 
mol%), dtbpy (10 mol%), B2pin2 (1.0 equiv) and it was evacuated and 
placed under N2 with three evacuation/refill cycles, before degassed 
MTBE was added. The vial was sealed with a crimp top septum cap 
and shaken to develop a deep red colour. Once it was homogeneous, 
the solution of vial A was added to vial B. The vial was heated (vide 
Scheme 2) for 1h or 4h. Upon completion (determinated by GC-MS) 
the volatiles were removed in vacuo to afford the crude boronate 
product. Pd(dppf)Cl2 (10 mol%), K2PO3 (1 equiv.) and aryl halide 
(Scheme 2; 1.3 equiv) were added, and the vial was sealed and 
purged with three evacuation/refill (Ar) cycles.  DMAc/H2O (2mL/1 mL) 
was added, and the mixture was heated to 80°C for 12h in an oil bath. 
The reaction mixture was diluted with water (10 mL) and extracted 
with AcOEt (3 × 10 mL). The combined organic extracts were washed 
with brine (10 mL), dried over anhydrous MgSO4, filtered through 
Celite, and concentrated in vacuo to afford the crude product. The 
residue was purified by pre-packed silica Redisep® Rf cartridges with 
the stated solvent gradient and at a constant flow rate of 35 mL/min 
using an automated Teledyne Isco CombiFlash Rf machine. 
3-phenylindolizine-1-carbonitrile 7a: From indolizine-1-carbonitrile 
(71 mg, 0.5 mmol) and iodobenzene (0.07 mL, 0.65 mmol), pre-packed 
silica Redisep® Rf cartridges (ethyl acetate/hexane 2/8), yield: 33 mg 
(30%), brown oil. 1H NMR (600 MHz, CDCl3, 25°C) δ 8.28 (d, J = 7.2 
Hz, 1H), 7.70 (d, J = 9.0 Hz, 1H), 7.55 – 7.50 (m, 4H), 7.46 – 7.42 (m, 
1H), 7.09 (ddd, J = 9.0, 6.6, 1.0 Hz, 1H), 7.05 (s, 1H), 6.74 (td, J = 6.8, 
1.3 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 138.6, 130.4, 129.4, 128.9, 
128.8, 127.1, 126.7, 123.9, 122.5, 118.4, 117.1, 116.4, 113.2, 82.4. 
Accurate mass (EI): calcd for C15H10N2 218.0844, found 218.0927.  
6-phenylindolizine-1-carbonitrile 8a: From indolizine-1-carbonitrile 
(71 mg, 0.5 mmol) and iodobenzene (0.07 mL, 0.65 mmol), pre-packed 
silica Redisep® Rf cartridges (ethyl acetate/hexane 1/9), yield: 11 mg 
(10%), brown oil. 1H NMR (600 MHz, CDCl3, 25°C) δ 8.20 (t, J = 1.3 Hz, 
1H), 7.71 (d, J = 9.2 Hz, 1H), 7.58 – 7.54 (m, 2H), 7.48 (dd, J = 8.4, 7.0 
Hz, 2H), 7.44 – 7.39 (m, 1H), 7.34 (dd, J = 9.3, 1.6 Hz, 1H), 7.31 (d, J 
= 3.0 Hz, 1H), 7.06 (d, J = 2.9 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 
129.3, 128.3, 127.6, 127.0, 123.4, 120.4, 118.0, 117.6, 117.0, 114,5. 
Accurate mass (EI): calcd for C15H10N2 218.0844, found 218.0952.  
3-(4-(trifluoromethyl)phenyl)indolizine-1-carbonitrile 7b: From 
indolizine-1-carbonitrile (71 mg, 0.5 mmol) and 1-bromo-4-
(trifluoromethyl)benzene (0.09 mL, 0.65 mmol), pre-packed silica 
Redisep® Rf cartridges (ethyl acetate/hexane 2/8), yield: 42 mg (33%), 
pale yellow solid, mp: 157-158°C. 1H NMR (700 MHz, CDCl3, 25°C) δ 
8.29 (dt, J = 7.1, 1.1 Hz, 1H, H-5), 7.80 – 7.76 (m, 2H), 7.72 (dt, J = 9.0, 
1.2 Hz, 1H, H-2’), 7.68 – 7.64 (m, 2H), 7.14 (ddd, J = 9.0, 6.6, 1.0 Hz, 
1H, H-7), 7.12 (s, 1H, H-3), 6.81 (td, J = 6.9, 1.3 Hz, 1H, H-6). 13C NMR 
(176 MHz, CDCl3) δ 139.0, 133.9, 130.5 (q, JF,C = 32,7 Hz, C-4’) 128.80, 
126.4 (q, JF,C = 3.7 Hz, 2C, C-3’, C-5’), 125.5, 124.8 (q, JF,C   272 Hz, 
CF3), 123.6, 123.2, 123.1, 118.6, 117.3, 116.5, 113.8, 83.1. Accurate 
mass (EI): calcd for C16H9F3N2 286.0718, found 286.0820.  
6-(4-(trifluoromethyl)phenyl)indolizine-1-carbonitrile 8b: From 
indolizine-1-carbonitrile (71 mg, 0.5 mmol) and 1-bromo-4-
(trifluoromethyl)benzene (0.09 mL, 0.65 mmol), pre-packed silica 
Redisep® Rf cartridges (ethyl acetate/hexane 2/8), yield: 17 mg (12%), 
brown oil. 1H NMR (600 MHz, CDCl3, 25°C) δ 8.11 (dd, J = 7.1, 0.9 Hz, 
1H, H-5), 7.87 (dd, J = 1.8, 0.9 Hz, 1H. H-8), 7.77 – 7.72 (m, 4H), 7.30 
(d, J = 3.1 Hz, 1H, H-3), 7.08 (d, J = 2.9 Hz, 1H, H-2), 7.04 (dd, J = 7.2, 
1.9 Hz, 1H, H-7).  13C NMR (151 MHz, CDCl3) δ 141.7, 137.9, 133.8, 
130.5 (q, JF,C  = 32.6 Hz, C-4’), 127.08, 126.86, 126.1 (q, JF,C = 3.7 Hz, 
C-3’, C-5’), 124.17 (q, JF,C = 272 Hz, CF3), 117.98, 116.81, 115.56, 
114.19, 112.58, 83.31. Accurate mass (EI): calcd for C16H9F3N2 
286.0718, found 286.0805.  
Dimethyl-5-(4-(trifluoromethyl)phenyl)indolizine-1,2-dicarboxylate 
10: From dimethyl indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) 
and 1-bromo-4-(trifluoromethyl)benzene (0.09 mL, 0.65 mmol), pre-
packed silica Redisep® Rf cartridges (ethyl acetate/hexane 1/9), yield: 
90 mg (48%), pale yellow solid, mp: 147°C. 1H NMR (600 MHz, CDCl3, 
25°C) δ 8.21 (ddd, J = 9.2, 1.2, 0.6 Hz, 1H, H-8), 7.83 (dt, J = 8.1, 0.8 
Hz, 2H, H-3’, H-5’), 7.73 – 7.70 (m, 2H,H-2’, H-6’ ), 7.57 (d, J = 0.7 Hz, 
1H, H-3), 7.17 (dd, J = 9.3, 6.8 Hz, 1H, H-7 ), 6.72 (dd, J = 6.8, 1.2 Hz, 
1H, H-6), 3.93 (s, 3H), 3.87 (s, 3H). 13C NMR (151 MHz, CDCl3) 13C 
NMR (151 MHz, CDCl3) δ 165.2, 164.4, 137.3, 137.1, 136.6, 132.5, 
132.3, 132.0 (q, JF,C = 32.8 Hz, C-4’) 130.4, 129.4, 126.4 (q, JF,C = 3.7 
Hz, C-3’, C-5’),126.6 (q, JF,C = 272 Hz, CF3), 123.33, 122.91, 121.90, 
120.32, 115.17, 114.86, 114.12, 103.75, 52.34, 51.57. Accurate mass 
(EI): calcd for C19H14F3NO4 377.0875, found 377. 0965.  
Dimethyl-6-(4-(trifluoromethyl)phenyl)indolizine-1,2-
dicarboxylate 11: From dimethyl indolizine-1,2-dicarboxylate (116.5 
mg, 0.5 mmol) and 1-bromo-4-(trifluoromethyl)benzene (0.09 mL, 
0.65 mmol), pre-packed silica Redisep® Rf cartridges (ethyl 
acetate/hexane 1/9), yield: 33 mg (12%), pale yellow solid, mp: 172-
173°C.  1H NMR (600 MHz, CDCl3, 25°C) δ 8.23 (dt, J = 9.5, 0.8 Hz, 
1H, H-8), 8.16 (dd, J = 1.6, 1.0 Hz, 1H, H-5), 7.77 – 7.72 (m, 2H, H-
3’, H-5’), 7.72 (s, 1H, H-3), 7.67 (dt, J = 8.0, 0.8 Hz, 2H, H-2’, H-6’), 
7.33 (dd, J = 9.5, 1.6 Hz, 1H, H-7), 3.93 (d, J = 1.0 Hz, 6H). 13C NMR 
(151 MHz, CDCl3) δ 164.8, 164.1, 140.4, 135.2, 130.3 (q, JF,C = 32.6 
Hz, C-4’), 127.1, 126.6, 126.1 (q, JF,C = 3.9 Hz, C-3’, C-5’), 126.11, 
126.1, 124.0 (q, JF,C = 272 Hz, CF3), 123.5, 123.3, 123.1, 122.3, 121.0, 
117.5, 103.3, 52.2, 51.4. Accurate mass (EI): calcd for C19H14F3NO4 
377.0875, found 377. 0965.  
Dimethyl-5,6-bis(4-(trifluoromethyl)phenyl)indolizine-1,2-
dicarboxylate 12: From dimethyl indolizine-1,2-dicarboxylate (116.5 
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mg, 0.5 mmol) and 1-bromo-4-(trifluoromethyl)benzene (0.09 mL, 
0.65 mmol), pre-packed silica Redisep® Rf cartridges (ethyl 
acetate/hexane 1/9), yield: 31 mg (12%), yellow solid, mp: 203-204°C. 
1H NMR (600 MHz, CDCl3, 25°C) δ 8.50 (d, J = 1.6 Hz, 1H, H-8), 7.90 
– 7.85 (m, 2H), 7.83 – 7.77 (m, 4H), 7.73 (d, J = 8.3 Hz, 2H), 7.59 (d, 
J = 0.6 Hz, 1H, H-3), 7.02 (d, J = 1.9 Hz, 1H, H-7), 3.95 (s, 3H), 3.89 
(s, 3H). 13C NMR (151 MHz, CDCl3) 165.4, 164.8, 142.2, 137.5, 137.4, 
135.2, 132.4, 132.2, 130.5, 130.3, 130.2, 129.3, 127.6, 127.0, 126.5 
(q, JF,C = 3.6 Hz, 2C), 126.0 (q, JF,C = 3.7 Hz, 2C), 125.4, 124.0 (q, 
JF,C = 272 Hz, CF3), 123.5 (q, JF,C = 298 Hz, CF3), 118.1, 115.7, 114.7, 
105.2, 52.8, 52.1. Accurate mass (EI): calcd for C26H17F6NO4 
521.1062, found 521.1141.  
General Procedure 2 - Preparation of TMPMgCl·LiCl in THF: In a 
dry and nitrogen-flushed Schlenk flask equipped with a magnetic 
stirring bar and was charged with i-PrMgCl·LiCl (1.0 M in THF, 20 mL, 
20 mmol). Then, 2,2,6,6-tetramethylpiperidine (3.52 mL, 21 mmol) 
was added dropwise through a syringe within 3 min. The mixture was 
stirred until the gas evolution ceased (24−48h). Titration against 
benzoic acid in THF (0°C) in the presence of 4-
(phenylazo)diphenylamine as the indicator showed the base 
concentration ranged from 0.90 to 0.98 M. 
General Procedure 3: Selective Magnesiation of indolizines: In a 
dry round-bottom flask sob N2 under magnetic stirring containing 2 mL 
of THF and start material (0.50 mmol), amounts of TMPMgCl·LiCl 
(vide Table 1 and Scheme 3) was added dropwise to the reaction 
mixture. After stirring for 1h to 5h (see Table 1 and Scheme 3) a 
solution of an appropriate electrophile (1.8 equiv) in THF (1.0 mL) was 
added, and the reaction mixture was kept under stirring for 6h (for 
iodine) to 12h (other electrophiles). The reaction was quenched with 
saturated aqueous NH4Cl, the products were extracted with ethyl 
acetate (3 × 15 mL), and the organic layer was dried over MgSO4. The 
solvent was removed under reduction pressure. The residue was 
purified by flash column chromatography (silica gel, ethyl 
acetate/hexanes). 
Dimethyl-5-iodoindolizine-1,2-dicarboxylate 13a: From dimethyl 
indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) and I2 (342.6.4 mg, 
0.9 mmol), silica gel (ethyl acetate/hexane: 2/8), yield: 156 mg (87%), 
brown solid, mp: 91-93ºC. 1H NMR (400 MHz, DMSO-d6, 25°C) δ 8.04 
(d, J = 9.1 Hz, 1H, H-8), 7.97 (s, 1H, H-3), 7.53 (dd, J = 7.1, 1.1 Hz, 
1H, H-6), 6.98 (dd, J = 9.1, 7.0 Hz, 1H, H-7), 3.83 (s, 3H), 3.80 (s, 
3H).13C NMR (101 MHz, DMSO -d6) δ  164.3, 163.4, 135.6, 125.9, 
124.4, 121.0, 120.7, 118.8, 103.6, 91.5, 52.1, 51.3. HRMS (ESI) m/z 
([M+H]+ calcd for C12H10INO4 359.9655, found 359.9729. 
Dimethyl-5-formylindolizine-1,2-dicarboxylate 13b: From dimethyl 
indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) and DMF (0.12 mL, 
1.5 mmol), silica gel (ethyl acetate/hexane: 3/7), yield: 78 mg (60%), 
brown oil. 1H NMR (500 MHz, DMSO-d6, 25°C) δ  9.95 (d, J = 10.5 
Hz, 1H), 8.99 (s, 1H, H-3), 8.31 (d, J = 9.0 Hz, 1H, H-8), 7.95 – 7.85 
(m, 1H, H-6), 7.43 (dd, J = 9.0, 7.0 Hz, 1H, H-7), 3.84 (d, J = 4.2 Hz, 
6H). 13C NMR (126 MHz, DMSO-d6) δ 187.0, 163.9, 163.1, 135.0, 
131.0, 128.6, 125.7, 122.4, 122.1, 117.8, 104.5, 52.0, 51.5. HRMS 
(ESI) m/z ([M+H]+ calcd for C13H11NO5 262.0637, found 262.0713.  
Dimethyl-3-(phenylthio)indolizine-1,2-dicarboxylate 14a: From 
dimethyl indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) and 
diphenylsulfane (131.0 mg, 0.6 mmol), silica gel (ethyl acetate/hexane: 
3/7), yield: 128 mg (75%), orange oil. 1H NMR (400 MHz, DMSO-d6, 
25°C) δ  8.44 (dd, J = 7.0, 1.2 Hz, 1H, H-8), 8.16 (dt, J = 9.0, 1.3 Hz, 
1H, H-5), 7.43 (ddd, J = 9.1, 6.9, 1.1 Hz, 1H, H-6), 7.31 – 7.24 (m, 2H), 
7.24 – 7.17 (m, 1H, H-7), 7.14 – 7.06 (m, 3H), 3.86 (s, 3H), 3.82 (s, 3H). 
13C NMR (101 MHz, DMSO-d6) δ  165.6, 163.0, 136.8, 133.7, 131.6, 
129.9, 127.3, 127.3, 126.7, 125.1, 119.6, 115.4, 110.1, 101.6, 53.0, 
51.7. HRMS (ESI) m/z ([M+H]+ calcd for C18H15NO4S 342.0722, found 
342.0796. 
5-iodoindolizine-1-carbonitrile and 2-iodoindolizine-1-carbonitrile 
15a and regioisomer: From  indolizine-1-carbonitrile (71 mg, 0.5 
mmol) and I2 (228.4 mg, 0,9 mmol), silica gel (ethyl acetate/hexane: 
8/2.).1H NMR  (400 MHz, CDCl3, 25°C) δ  8.10 (dd, J = 7.0 Hz, 1Hz, 
1H), 7.66 (d, J = 8.9 Hz, 1.07 H), 7.62 (dd, J = 9.0 Hz, 1.0 Hz, 0.92 H), 
7.55 (d, J = 3.0 Hz, 0.92 H), 7.29 (d, J = 7.0 Hz, 1.20 H), 7.21 (s, 0.93 
H), 7.10-7.14 (m, 1.96 H), 6.91 (t, J = 6.8 Hz, 1.17 H), 6.80 (dd, J = 9.0 
Hz, 7.0 Hz, 1.02 H). 13C NMR (100 MHz, CDCl3) δ  140.4, 138.3, 127.2, 
125.3, 125.2, 122.7, 122.4, 119.1, 117.7, 117.6, 116.5, 115.7, 113.8, 
88.1, 84.7. Note: proportional integration of H. 96:4 (product 15a). 
5-iodoindolizine-1-carbonitrile 15a: From indolizine-1-carbonitrile (71 
mg, 0.5 mmol) and I2 (228.4 mg, 0.9 mmol), silica gel (ethyl 
acetate/hexane: 8/2.), yield: 104 mg (78%), green solid, mp: 131°C, IR 
(KBr): 2976, 2917, 2211, 1490, 1293, 1179, 765, 725, 684. 1H NMR  
(400 MHz, CDCl3, 25°C ) δ  7.66 (d, J = 8.8 Hz, 1H), 7.54 (d, J = 3.0 
Hz, 1H), 7.29 (d, J = 7.0 Hz, 1H), 7.11 (d, J = 3.0 Hz, 1H), 6.80 (dd, J = 
8.8 Hz, 7.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 138.3, 125.3, 122.4, 
119.1, 117.6, 116.5, 113.8, 88.1, 84.6. HRMS (ESI) m/z 268.9570 
([M+H]+ calcd for  C9H5IN2: 268.9573.  
2-(1-hydroxy-2-methylpropyl)indolizine-1-carbonitrile 16a: From 
indolizine-1-carbonitrile (71 mg, 0.5 mmol) and isobutyraldehyde (0.09 
mL, 0.9 mmol), silica gel (ethyl acetate/hexane: 3/7), yield: 88 mg 
(82%), brown oil. IR (KBr): 3429, 2962, 2873, 2211, 1513, 1461, 1368, 
1311, 1162, 1011, 829, 745.  1H NMR (400 MHz, DMSO-d6, 25°C) δ  
8.34 (d, J = 7.0 Hz, 1H), 7.55 (d, J = 9.0 Hz, 1H), 7.05 (ddd, J = 9.0 Hz, 
7.0 Hz, 0.8 Hz, 1H), 6.87 (s, 1H), 6.76 (td, J = 7.0 Hz, 1.1 Hz, 1H), 4.59 
(d, J = 8.0 Hz, 1H), 2.29 (sext, J = 6.7 Hz, 1H), 1.15 (d, J = 6.6 Hz, 3H), 
6.86 (d, J = 6,6 Hz, 3H).13C NMR (101 MHz, DMSO-d6) δ  138.6, 126.8, 
125.4, 122.2, 117.6, 117.1, 115.0, 112.5, 80.1, 72.5, 31.9, 19.7, 18.6. 
HRMS (ESI) m/z ([M+H]+ calcd for C13H14N2O + Na+ 237.0998, found 
237.100. 
3-(trimethylsilyl)indolizine-2-carbonitrile 17a: From indolizine-1-
carbonitrile (71 mg, 0.5 mmol) and TMSCl (0.12 mL, 0.9 mmol), silica 
gel (ethyl acetate/hexane: 8/2.), yield: 72 mg (67%), grey oil. IR (KBr): 
3128, 3055, 2960, 2226, 1519, 1422, 1349, 1310, 1249, 1120, 772, 
627. 1H NMR  (400 MHz, CDCl3, 25°C) δ   8.03 (dd, J = 7.1 Hz, 1.0 Hz, 
1H), 7.41 (dt, J = 9.0 Hz, 1.1 Hz, 1H), 6.83 (ddd, J = 9.0 Hz, 6.5 Hz, 1.0 
Hz, 1H), 6.77 (s, 1H), 6.63 (m, 1H), 0.52 (s, 9H), 13C NMR  (100 MHz, 
CDCl3) δ  136.1, 128.9, 126.2, 120.0, 119.6, 118.0, 112.8, 105.8, 105.4, 
-0.77 (3C). HRMS (ESI) m/z ([M+H]+ calcd for C12H14N2Si  215.0999, 
found 215.1005.  
3-chloroindolizine-2-carbonitrile 17b: From indolizine-1-carbonitrile 
(71 mg, 0.5 mmol) and hexachloroethane (214 mg, 0.9 mmol), silica gel 
(ethyl acetate/hexane: 8/2.), yield: 45 mg (51%), grey oil. 1H NMR  (400 
MHz, CDCl3, 25°C) δ  7.91 (d, J = 7.0 Hz, 1H), 7.38 (d, J = 9.0 Hz, 1H), 
6.77-6.86 (m, 2H), 6.73 (s, 1H), 13C NMR  (CDCl3, 100 MHz) δ  131.7, 
121.6, 119.8, 119.3, 114.4, 113.7, 112.5, 102.0, 96.6. HRMS (ESI) m/z 
([M+H]+ calcd for  C9H5ClN2 177.0141, found 177.0160. 
General Procedure 4: Selective magnesiation of indolizines 
followed by Negishi Cross Coupling Reaction: After magnesiation 
step (according to GP3), the temperature was warmed at 0ºC, and 
ZnCl2 (1.0 M in THF, 2.0 equiv) was added dropwise to the reaction 
mixture. The temperature was kept for 30 min. Then, a THF solution of 
[Pd(PPh3)4] (10 mol%) and 1 mL of a THF solution of appropriate 
electrophile (1.8 equiv) were added, and the reaction mixture was kept 
under stirring for 12h at 60°C. The reaction was quenched with 
saturated aqueous NH4Cl; the products were extracted with ethyl 
acetate (3 × 15 mL), and the organic layer was dried over MgSO4. The 
solvent was removed under reduction pressure. The residue was 
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purified by flash column chromatography (silica gel, ethyl 
acetate/hexanes). Results are presented in Table 1. 
Dimethyl 3-phenylindolizine-1,2-dicarboxylate 14b: From dimethyl  
indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) and iodobenzene 
(0.10 mL, 0.9 mmol) silica gel (ethyl acetate/hexane 2/8), yield 99 mg 
(64%), green oil.1H NMR (400 MHz, CDCl3, 25°C) δ 8.23 (dt, J = 9.1, 1.3 
Hz, 1H), 8.05 (dt, J = 7.1, 1.1 Hz, 1H), 7.51 (dd, J = 4.2, 0.8 Hz, 4H), 7.49 
– 7.45 (m, 1H), 7.13 (ddd, J = 9.2, 6.6, 1.1 Hz, 1H), 6.72 (td, J = 6.9, 1.4 
Hz, 1H), 3.91 (s, 3H), 3.81 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.0, 
164.4, 135.4, 130.1, 129.2, 129.0, 125.2, 123.7, 122.2, 120.5, 113.6, 
102.1, 52.6, 51.4. HRMS (ESI) m/z ([M+H]+ calcd for C18H15NO4 
310.1001, found 310. 1069. 
Dimethyl 3-(4-(trifluoromethyl)phenyl)indolizine-1,2-dicarboxylate 
14c: From  dimethyl indolizine-1,2-dicarboxylate (116.5 mg, 0.5 mmol) 
and 1-bromo-4-(trifluoromethyl)benzene (0.12 mL, 0.9 mmol), silica gel 
(ethyl acetate/hexane 2/8), yields 143 mg (76%).1H NMR (400 MHz, 
CDCl3, 25°C) δ 8.26 (dt, J = 9.1, 1.2 Hz, 1H, H-8), 8.03 (dt, J = 7.2, 1.1 
Hz, 1H, H-5), 7.81 – 7.74 (m, 2H), 7.70 – 7.63 (m, 2H), 7.21 – 7.13 (m, 
1H, H-7), 6.78 (td, J = 6.9, 1.3 Hz, 1H, H-6), 3.91 (s, 3H), 3.82 (s, 3H).13C 
NMR (101 MHz, CDCl3) δ 166.64, 164.19, 135.72, 130.42, 126.3 (q, JF,C 
= 3.1, 2.7 Hz, 2C, C-3‘, C5‘), 124.1 (q, JF,C = 272 Hz, CF3), 120.8, 114.1, 
102.7, 52.8, 51.6. HRMS (ESI) m/z ([M+H]+ calcd for C19H14F3NO4 
378.0875, found 378.0941. 
General Procedure 5: Selective Lithiation of indolizines using 
LDA: In a dry round-bottom flask under magnetic stirring, LDA was 
prepared by addition of n-butyllithium (2.35 M in hexanes, 0.70 mmol, 
0.30 mL, 1.4 equiv) to a solution of diisopropylamine (0.77 mmol, 
0.10mL, 1.54 equiv) in THF (1 mL) at −70°C. After 15 min, the reaction 
mixture was warmed to 0°C and stirred for 20 min at the same 
temperature. After, indolizine-carbonitrile (71 mg, 0.5 mmol) in THF (2 
mL) was added dropwise to the reaction mixture. After stirring for 30 
min at 0°C, a solution of an appropriate electrophile (1.8 equiv) in THF 
(1.0 mL) was added, and the reaction mixture was kept under stirring 
for 2h (for iodine) and 12h (other electrophiles). The reaction was 
quenched with saturated aqueous NH4Cl, the products were extracted 
with ethyl acetate (3 × 15mL), and the organic layers were dried over 
MgSO4. The solvent was removed under reduced pressure. The 
residue was purified by flash column chromatography (silica gel, 
hexanes/ethyl acetate). Results are presented in Scheme 3.  
5-(1-hydroxy-2-methylpropyl)indolizine-1-carbonitrile 15b : From 
indolizine-1-carbonitrile (71 mg, 0,5 mmol) and isobutyraldehyde (0.09 
mL, 0.9 mmol), silica gel (ethyl acetate/hexane: 3/7), yield: 79 mg 
(74%), brown oil. IR (KBr): 3426, 3104, 2962, 2928, 2867, 2203, 1520, 
1464, 1389, 1259, 1159, 1010, 787, 695.1H NMR  (400 MHz, CDCl3, 
25°C) δ  7.44-7.46 (m, 2H), 7.05 (dd, J = 8.9 Hz, J = 6.8 Hz, 1H), 6.96 
(d, J = 3.0 Hz, 1H), 6.81 (d, J = 6.7 Hz, 1H), 4.70 (d, J = 6.4 Hz, 1H), 
2.29 (sext, J = 6.6 Hz, 1H), 1.03 (d, J = 6.6 Hz, 3H), 0.94 (d, J = 6.6 Hz, 
3H).13C NMR (100 MHz, CDCl3) δ  139.5, 138.9, 122.1, 117.2, 116.4, 
116.3, 112.4, 111.1, 81.1, 77.3, 77.0, 76.6, 75.9, 30.1, 19.7, 17.3. 
HRMS (ESI) m/z ([M+H]+ calcd for C13H14N2O + Na+ 237.0998 found 
237.1003. 
General Procedure 6: Selective Magnesiation of indolizines 
using TMP2MgCl∙2LiCl: In a dry round-bottom flask under magnetic 
stirring, TMP2MgCl∙2LiCl was prepared by addition of n-butyllithium 
(2.48 M in hexanes, 1.0 mmol, 0.40 mL) to a solution of 
TMPMgCl∙LiCl ( 1.05 mmol, 0.18 mL) in THF (2 mL) at -70 °C. After 
5 min, the reaction mixture was warmed to 0°C and stirred for 30 min 
at the same temperature. A solution of TMPMgCl∙LiCl (1.0 M in THF, 
1.0 mmol, 1mL) was added dropwise to the reaction mixture. The 
temperature was held at 0°C for 15 min and warmed up to room 
temperature. After 30 min, a solution of indolizine-2-carbonitrile (71 
mg, 0.5 mmol in THF (2 mL) was added. After stirring for 1h at room 
temperature, a solution of an appropriate electrophile (1.8 equiv) in 
THF (1.0 mL) was added, and the reaction mixture was kept under 
stirring for 2h (for iodine) and 12h (other electrophiles). The reaction 
was quenched with saturated aqueous NH4Cl, the products were 
extracted with ethyl acetate (3 × 15mL), and the organic layers were 
dried over MgSO4. The solvent was removed under reduced 
pressure. The residue was purified by flash column chromatography 
(silica gel, ethyl acetate/hexanes). Results are presented in Scheme 
3.  
5-iodoindolizine-2-carbonitrile 18a: From dimethyl  indolizine-2-
carbonitrile (71 mg, 0,5 mmol) and I2 (228.4 mg, 0,9 mmol), silica gel 
(ethyl acetate/hexane: 8/2.), yield: 104 mg (78%), pale yellow solid, 
mp: 140-142°C. IR (KBr): 3133, 3119, 2962, 2229, 1493, 1288, 1207, 
1125, 788, 721. 1H NMR   (400 MHz, CDCl3, 25°C) δ  7.95 (m, 1H), 
7.42 (d, J = 9.0 Hz, 1H), 7.19 (dd, J = 6.9 Hz, 1.0 Hz, 1H), 6.93 (d, J 
= 1.6 Hz, 1H), 6.56 (dd, J = 9.0 Hz, 6.9 Hz, 1H). 13C NMR (400 MHz, 
CDCl3) δ 133.2, 125.5, 122.9, 119.9, 119.6, 115.9, 105.0, 97.2, 85.8. 
HRMS (ESI) m/z ([M+H]+ calcd for C9H5IN2  268.9570, found 
268.9574.  
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